THE EXPERIENCE OF TREGALOZA BASED LUBRICANT USAGE FOR PATIENTS WHO UNDERWENT EXCIMER LASER SURGERY
https://doi.org/10.18008/1816-5095-2016-3-213-218
Abstract
Purpose: to evaluate the tregalose based eye drops effectiveness in patients who underwent PRK or TransPRK surgery. patients and methods: 50 patients with moderate myopia were examined before, 7 days and 1 month after PRK or TransPRK surgery made by SCHWIND Amaris excimer laser by the same surgeon. In addition to conventional diagnostics, Schirmer test and tear break up time were performed as well as ODSI questionare and Oxford index of ocular surface disorders were investigated. Patients were divided in two groups, Study group — “Thealos” group and “Control” group. In both groups patients have started using non preservative eye drops based on tregalosa and hyaluronic acid 4-th day after surgery respectively. results: The tear film breakup time was significantly better in “Thealos” group (7,22±3,61 sec 7 days postop and 9,36±3,68 sec 1 month postop in comparison to «Control” group 5,21±0,25 (р<0,01) sec and 7,21±2,85 sec respectively (р<0,05)) as well as ocular surface index score in “Thealos” group post surgery was less (0,26±0,38 и 0,85±0,31 marks 7 days postop (р<0,05) and 0,09±0,19 and 0,21±0,4 (р<0,05) 1 month postop respectively). There were no other statistically significant differences found in analysed data. Conclusion: Using of “Thealoz” non-preservative eye drops leads to faster recovery after surface excimer laser ablations in terms of dry eye manifestation, those as tearfilm stability and ocular surface index score, measured using “Oxford” scale. Moistening properties of tregaloze solution could be compared with those of hyaluronic acid solution.
About the Authors
E. EskinaRussian Federation
MD, prof., chief medical officer, «Sphere”
V. A. Parshina
Russian Federation
ophthalmologist, «Sphere”
M. Stepanova
Russian Federation
ophthalmologist, «Sphere”
References
1. Toda I.,Yagi Y., Hata S. Eximer laser photorefractive keratectomy for patients with contact lens intolerance caused by dry eye. Br. J. Ophtalmol. 1996;80(7): 604 609.
2. Quinto G.G., Camacho W., Behrens A. Post refractive surgery dry eye. Curr Opin Ophthalmol. 2008;19(4):335–341.
3. Albietz JM(1), McLennan SG, Lenton LM. Ocular surface management of photorefractive keratectomy and laser in situ keratomileusis . J Refractive Surgery. 2003; Nov Dec;19(6):636 44.
4. E.N. Eskina, O.I. Rjabenko, I.S. Jushkova, V.A. Parshina, M.A. Stepanova. [Evaluation of transepithelial photorefractive keratectomy (PRK) in correction of high myopia (6 months follow up)]. Ocenka rezul’tatov transjepitelial’noj fotorefrakcionnoj keratjektomii (FRK) v korrekcii miopii vysokoj stepeni (6 mesjacev nabljudenija). [Practical medicine]. Prakticheskaja medicina. 2012;1(4(59):59 60. (in Russ.).
5. Beheshtnejad AH, Hashemian H, Kermanshahani AM Evaluation of Tear Osmolarity Changes Aſter Photorefractive Keratectomy. Cornea. 2015; Dec;34(12):1541 4.
6. Raoof D, Pineda R. Dry eye aſter laser in situ keratomileusis. Semin. Ophthalmol. 2014; Sep Nov;29(5 6):358 62.
7. Pavlova Ju. A., Somov E. E. [The «dry eye» syndrome of patients undergoing laser in situ keratomileusis]. Sindrom «suhogo glaza» u pacientov, perenesshih lazernyj keratomilez in situ. [Russian Pediatric Ophthalmology]. Rossijskaja pediatricheskaja oſtal’mologija. 2009;2:38 40. (in Russ.).
8. Oganezova Zh. G. [Hyaluronic acid drugs in the treatment of dry eye syndrome]. Preparaty na osnove gialuronovoj kisloty v lechenii sindroma «suhogo glaza. RMZh. [«Clinical Ophthalmology» Russian Medical Journal]. «Klinicheskaja Oſtal’mologija». 2013;3:119. (in Russ.).
9. Mencucci R, Boccalini C, Caputo R. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear film in stability aſter cataract surgery. J Cataract Refract Surg. 2015; Aug; 41(8):1699 704.
10. A. Hill Bator, M. Misiuk HojBo, K. Marycz, J. Grzesiak «Trehalose Based Eye Drops PreserveViability and Functionality of Cultured Human Corneal Epithelial Cellsduring Desiccation» . Hindawi Publishing Corporation BioMed, vol.2014; 8.
11. T. Matsuo. “Trehalose protects corneal epithelial cells from death by drying. British Journal of Ophthalmology. 2001;85(5): 610–612.
12. Leslie SB, Israeli E, Lighthart B, et. all. Trehalose and sucrose protect both membrane sand proteins in intact bacteria during drying. Appl. Environ Microbiol. 1995; 61.
13. N. Guo, I. Puhlev, D. R. Brown, J. Mansbridge, and F. Levine, Trehalose expression confers desiccation to lerance on human cells. Nature Biotechnology. 2000;18(2):168– 171.
14. Filippenko N. G., Povetkin S. V. [Methodical bases of clinical trials and statistical data processing]. Kursk: 2010. (in Russ.).
15. Grzhibovskij A. M. [Analysis of quantitative data for two independent groups]. Analiz kolichestvennyh dannyh dlja dvuh nezavisimyh grupp. [Human Ecology]. Jekologija cheloveka. 2008;2:54 61. (in Russ.).
16. Barber B.L., Strahlman E.R., Laibovitz R., Guess H.A., Reines S.A. Validation of questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology. 1997; Feb; 104 (2):334–342.
17. Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. Oct; 2003;22(7):640 – 650.
18. V. V. Brzheskij, E. E. Somov. [Corneal conjunctival xerosis]. Saint Petersburg: Levsha; 2003. (in Russ.).
19. Dzh. Dzh. Kanski [Clinical ophthalmology]. Moscow: Logosfera; 2009. (in Russ.).
20. Shiffman RM, Christianson MD, Jacobsen G, Hirsh JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophtalmol. 2000;118:615 62.
Review
For citations:
Eskina E., Parshina V.A., Stepanova M. THE EXPERIENCE OF TREGALOZA BASED LUBRICANT USAGE FOR PATIENTS WHO UNDERWENT EXCIMER LASER SURGERY. Ophthalmology in Russia. 2016;13(3):213-218. (In Russ.) https://doi.org/10.18008/1816-5095-2016-3-213-218